Largest biotech companies by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 biotech companies ranked by total debt, at CHF 46.1B, ahead of Gilead Sciences (CHF 21B) and Biogen (CHF 5.3B). Figures as of 18 Nov 2026, 19:11 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenCHF 46.1B
Median
CHF 497.7M
Combined market value
CHF 705.8B
Countries
5
Not ranked
13no total debt on file

Market values as of .

All countries
All sectors
Biotech
CHF
Clear filters
Largest biotech companies by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareCHF 46.1BCHF 202.3BCHF 373.99 3.18% down 34% up United States
2Gilead SciencesGILD · Health CareCHF 21BCHF 176.6BCHF 142.36 0.88% down 33% up United States
3BiogenBIIB · Health CareCHF 5.3BCHF 31.2BCHF 211.31 0.12% down 49% up United States
4Halozyme TherapeuticsHALO · Health CareCHF 1.8BCHF 9.2BCHF 81.05 0.12% up 37% up United States
5QiagenQGEN · Health CareCHF 1.4BCHF 8.7BCHF 41.92 0.12% down 12% up Netherlands
6ModernaMRNA · Health CareCHF 497.7MCHF 67.9BCHF 167.76 3.83% down 755% up United States
7RepligenRGEN · Health CareCHF 457.4MCHF 9.2BCHF 144.66 5.74% up 5% up United States
8Bio-TechneTECH · Health CareCHF 168.7MCHF 9.6BCHF 61.40 0.21% up 26% up United States
9Adaptive BiotechnologiesADPT · Health CareCHF 110.7MCHF 3.9BCHF 24.13 0.39% up 88% up United States
10Scholar Rock HoldingSRRK · Health CareCHF 84.1MCHF 4.9BCHF 40.02 5.25% up 14% up United States
11CG OncologyCGON · Health CareCHF 2.5MCHF 6BCHF 66.85 0.39% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8436 CHF). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech companies rank first by total debt?

Amgen (CHF 46.1B), Gilead Sciences (CHF 21B) and Biogen (CHF 5.3B) are the top three of the 11 biotech companies ranked by total debt as of 18 Nov 2026, 19:11 UTC.

How many biotech companies are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 11 biotech companies ranked by total debt have a combined market value of CHF 705.8B as of 18 Nov 2026, 19:11 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech companies by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.